POM Investment Strategies’s Eli Lilly LLY Stock Holding History

POM Investment Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Buy	225 +172	+325%	+$174K	0.26%	50
2025 Q4	$57.2K	Buy	53 +51	+2,550%	+$48.8K	0.03%	62
2025 Q3	$1.53K	Buy	+2	New	+$1.49K	﹤0.01%	171
2025 Q1	–	Sell	-186	Closed	-$144K	–	294
2024 Q4	$144K	Hold	186	–	–	0.11%	46
2024 Q3	$165K	Sell	186 -46	-20%	-$41.4K	0.13%	36
2024 Q2	$210K	Buy	232 +82	+55%	+$65.6K	0.17%	33
2024 Q1	$117K	Hold	150	–	–	0.1%	45
2023 Q4	$87.4K	Buy	+150	New	+$87.6K	0.08%	47

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

POM Investment Strategies's LLY Position: Q1 2026 in Review

POM Investment Strategies increased its Eli Lilly (LLY) stake by 325% in Q1 2026, buying an estimated $174K and bringing the position to 225 shares worth $207K. The position accounts for 0.26% of the portfolio, ranked #50.

POM Investment Strategies first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $210K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

POM Investment Strategies held 225 shares of Eli Lilly worth $207K as of Q1 2026.
POM Investment Strategies bought 172 Eli Lilly shares in Q1 2026, an estimated $174K.
Eli Lilly made up 0.26% of POM Investment Strategies's portfolio in Q1 2026, its #50 holding.
POM Investment Strategies first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
POM Investment Strategies's Eli Lilly position peaked at $210K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on POM Investment Strategies's 13F filing for Q1 2026, filed 11 May 2026.